The impact of using vasopressin at the time of removal of ovarian endometriosis cyst on a woman's egg count and endometriosis-related quality of life.
Not Applicable
Recruiting
- Conditions
- EndometriosisSurgery - Surgical techniquesReproductive Health and Childbirth - Fertility including in vitro fertilisation
- Registration Number
- ACTRN12620001327976
- Lead Sponsor
- Sydney Women's Endosurgery Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Women undergoing laparoscopic removal of endometrioma.
Exclusion Criteria
Women who have significant medical conditions such as: hypertension, cardiac disease, diabetes mellitus, severe renal or hepatic disease; or women who have previously participated in this trial; or those with hypersensitivity to vasopressin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method